NetraMark Holdings, Inc. engages in the development of artificial intelligence and machine learning solutions. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-06-08. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
AINMF stock price ended at $0.76 on 水曜日, after rising 0.00%
On the latest trading day Jan 14, 2026, the stock price of AINMF rose by 0.00%, climbing from $0.76 to $0.76. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.76 and a high of $0.76. Alongside this price increase, trading volume also rose by 2.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 500 shares were traded, amounting to a market value of approximately $65.2M.